If this is your first visit, be sure to check out the FAQ by clicking the link above. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. |
|
|
Thread Tools | Display Modes |
#71
|
|||
|
|||
Splenda tablets - Why can't Johnson & Johnson sell them in the US?
Sun, 21 Mar 2004 02:54:16 +0200 in article
Matti Narkia wrote: Here is the abstract of a very recent toxicology review of Stevia: Geuns JM. Stevioside. Phytochemistry. 2003 Nov;64(5):913-21. PMID: 14561506 [PubMed - in process] URL:http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=145615 06&dopt=Abstract Laboratory of Plant Physiology, Catholic University of Leuven, Kasteelpark Arenberg 31, B 3001 Leuven, Belgium. Abstract: "Stevioside is a natural sweetener extracted from leaves of Stevia rebaudiana (Bertoni) Bertoni. The literature about Stevia, the occurrence of its sweeteners, their biosynthetic pathway and toxicological aspects are discussed. Injection experiments or perfusion experiments of organs are considered as not relevant for the use of Stevia or stevioside as food, and therefore these studies are not included in this review. The metabolism of stevioside is discussed in relation with the possible formation of steviol. Different mutagenicity studies as well as studies on carcinogenicity are discussed. Acute and subacute toxicity studies revealed a very low toxicity of Stevia and stevioside. Fertility and teratogenicity studies are discussed as well as the effects on the bio-availability of other nutrients in the diet. The conclusion is that Stevia and stevioside are safe when used as a sweetener. It is suited for both diabetics, and PKU patients, as well as for obese persons intending to lose weight by avoiding sugar supplements in the diet. No allergic reactions to it seem to exist." I happen to have the full text of the above review article in PDF form, which I could lend to interested individuals, please contact me by email. Below the references from the full text article: References Alves et al., 1979. L.M. Alves and M. Ruddat, The presence of gibberelling A20 in Stevia rebaudiana and its significance for the biological activity of steviol. Plant Cell Physiol. 20 (1979), pp. 123–130. Akashi and Yokoyama, 1975. H. Akashi and Y. Yokoyama, Security of dried-leaf extracts of Stevia. Toxicological tests. Food Industry 18 (1975), pp. 34–43. Anonymous, 1996. Anonymous, 1996. Voedingsaanbevelingen voor België, (D/1996/7795/12) Ed. G. De Backer, Zevecotestraat 43, B-9830 Sint-Martens-Latem, pp 77. Aze et al., 1991. Y. Aze, K. Toyoda, K. Imaida, S. Hayashi, T. Imazawa, Y. Hayashi and M. Takahashi, Subchronic oral toxicity study of stevioside in F344 rats. Bull. Nat. Inst. Hyg. Sc 109 (1991), pp. 48–54. Bearder et al., 1975. J.R. Bearder, J. MacMillan and C.M. Wels, The metabolism of steviol to 13-hydroxylated ent-gibberellanes and ent-keuranes. Phytochemistry 14 (1975), pp. 1741–1748. Abstract | Abstract + References | PDF (810 K) Boeckh-Haebisch, 1992. E.M.A. Boeckh-Haebisch, Pharmacological Trial of a concentrated crude extract of Stevia rebaudiana (Bert) Bertoni in healthy volunteers. Arq. Biol. Tecnol. 35 2 (1992), pp. 299–314. Bracht et al., 1985. A.M. Bracht, F.S. Kemmelmeier, E.L. Ishii, M. Alvarez and A. Bracht, Effect of Stevia rebaudiana natural products on cellular and sub-cellular metabolism. Arq. Biol. Tecnol. 28 (1985), pp. 431–455. Brandle et al., 2002. J.E. Brandle, A. Richman, A.K. Swanson and B.P. Chapman, Leaf ESTs from Stevia rebaudiana: a resource for gene discovery in diterpene synthesis. Plant Mol. Biol. 50 (2002), pp. 613–622. Chan et al., 2000. P. Chan, B. Tomlinson, Y.-J. Chen, J.-C. Liu, M.-H. Hsieh and J.-T. Cheng, A double-blind placebo-controlled study pf the effectiveness and tolerability of oral stevioside in human hypertension. Br. J. Clin. Pharmacol. 50 (2000), pp. 215–220. Chan et al., 1998. P. Chan, D.-Y. Xu, J.-C. Liu, Y.-J. Chen, B. Tomlinson, W.-P. Huang and J.-T. Cheng, The effect of stevioside on blood pressure and plasma catecholamines in spontaneously hypertensive rats. Life Sci. 63 (1998), pp. 1679–1684. Abstract | Full Text + Links | PDF (440 K) Compadre et al., 1988. C.M. Compadre, R.A. Hussain, N.P.D. Nanayakkara, J.M. Pezzuto and A.D. Kinghorn, Mass spectral analysis of some derivatives and in vitro metabolites of steviol, the aglycone of the natural sweeteners, stevioside, rebaudioside A and rubusoside. Biomed. Environ. Mass Spectrom. 15 (1988), pp. 211–222. Curi et al., 1986. R. Curi, M. Alvarez, R.B. Bazotte, L.M. Botion, J.L. Godoy and A. Bracht, Effect of Stevia rebaudiana on glucose tolerance in normal adult humans. Brazilian J. Med. Biol. Res. 19 (1986), pp. 771–774. Das et al., 1992. S. Das, A.K. Das, R.A. Murphy, I.C. Punwani, M.P. Nasution and A.D. Kinghorn, Evaluation of the Cariogenic Potential of the Intense Natural Sweeteners Stevioside and Rebaudioside A. Caries Res. 26 (1992), pp. 363–366. de Oliveira and Strapasson, 1996. B.H. de Oliveira and R.A. Strapasson, Biotransformation of isosteviol by Fusarium verticilloides. Phytochemistry 43 (1996), pp. 393–395. Abstract | Abstract + References | PDF (191 K) de Oliveira et al., 1999. B.H. de Oliveira, M.C. dos Santos and P.C. Leal, Biotransformation of the diterpenoid, isosteviol, by Aspergillus niger, Penicillium chrysogenum and Rhizopus arrhizus. Phytochemistry 51 (1999), pp. 737–741. Abstract | Full Text + Links | PDF (128 K) Gardana et al., 2003. Gardana, C., Simonetti, P., Canzi, E., Zanchi, R., Pietta, P.G. Metabolism of stevioside and rebaudioside A from Stevia rebaudiana extracts by human microflora. J. Agric. Food Chem. (submitted). Geuns, 2002. J.M.C. Geuns, Safety evaluation of Stevia and stevioside. In: Atta-ur-Rahman, Editor, Studies in Natural Products Chemistry, Vol. 27: Bioactive Natural Products (Part H), Elsevier, Amsterdam (2002), pp. 299–319. Geuns et al. in press a. Geuns, J.M.C., Augustijns, P., Mols, R., Buyse, J.G., Driessen, B. Metabolism of stevioside in pigs and intestinal absorption characteristics of Stevioside, Rebaudioside A and Steviol. Food Chem. Toxicol. (in press a). Geuns et al., 2003b. J.M.C. Geuns, R.D. Malheiros, V.M.B. Moraes, E.M.-P. Decuypere, F. Compernolle and J.G. Buyse, Metabolism of stevioside by chickens. J. Agric. Food Chem. 51 (2003), pp. 1095–1101. Geuns et al., in press b. Geuns, J.M.C., Bruggeman, V., and Buyse, J.G. Effect of stevioside and steviol on the developing broiler embryos. J. Agric. Food Chem. (in press b). Gianfagna et al., 1983. T. Gianfagna, J.A.D. Zeevaart and W.J. Lusk, Synthesis of [2H]gibberellins from steviol using the fungus Gibberella fujikuroi. Phytochemistry 22 (1983), pp. 427–430. Abstract | Full Text + Links | PDF (452 K) Hagiwara et al., 1984. A. Hagiwara, S. Fukushima and M. Kitaori, Effects of the three sweeteners on rats urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Gann. 75 (1984), pp. 763–768. Hersenhorn et al., 1997. J. Hersenhorn, M. Zohar, B. Crammer, Z. Ziv, V. Weinstein, Y. Kleifeld, Y. Lavan and R. Ikan, Plant-growth regulators derived from the sweetener stevioside. Plant Growth Regulation 23 (1997), pp. 173–178. Hutapea et al., 1997. A.M. Hutapea, C. Toskulkao, D. Buddhasukh, P. Wilairat and T. Glinsukon, Digestion of Stevioside, a Natural Sweetener, by Various Digestive Enzymes. J. Clin. Biochem. Nutr. 23 (1997), pp. 177–186. Hutapea et al., 1999. A.M. Hutapea, C. Toskulkao, P. Wilairat and D. Buddhasukh, High-performance liquid chromatographic separation and quantitation of stevioside and its metabolites. J. Liq. Chrom. Rel. Technol. 22 (1999), pp. 1161–1170. Huxtable, 2002. R.J. Huxtable, Pharmacology and toxicology of stevioside, rebaudioside A, and steviol. In: A.D. Kinghorn, Editor, Stevia, the Genus Stevia. Medicinal and Aromatic Plants––Industrial Profiles, Vol. 19, Taylor and Francis, London and NY (2002), pp. 160–177. Kennelly, E.J., 2002. E.J. Kennelly, Sweet and non-sweet constituents of Stevia rebaudiana (Bertoni) Bertoni. In: A.D. Kinghorn, Editor, Stevia, the Genus Stevia. Medicinal and Aromatic Plants––Industrial Profiles, Vol. 19, Taylor and Francis, London and NY (2002), pp. 68–85. Kinghorn, A.D., 2002. A.D. Kinghorn, Overview. In: A.D. Kinghorn, Editor, Stevia, the Genus Stevia. Medicinal and Aromatic Plants––Industrial Profiles, Vol. 19, Taylor and Francis, London and NY (2002), pp. 1–17. Kim et al., 1996a. K.K. Kim, H. Yama****a, Y. Sawa and H. Shibata, A high activity of 3-hydroxy-3-methylglutaryl Coenzyme A Reductase in chloroplasts of Stevia rebaudiana Bertoni. Biosc. Biotech. Biochem. 60 (1996), pp. 685–686. Kim et al., 1996b. K.K. Kim, Y. Sawa and H. Shibata, Hydroxylation of ent-kaurenoic acid to steviol in Stevia rebaudiana Bertoni––purification and partial characterization of the enzyme. Arch. Biochem. Biophys. 332 (1996), pp. 223–230. Abstract | PDF (177 K) Kim et al., 2002. J. Kim, Y.H. Choi and Y.-H. Choi, Use of stevioside and cultivation of Stevia rebaudiana in Korea. In: A.D. Kinghorn, Editor, Stevia, the Genus Stevia. Medicinal and Aromatic Plants––Industrial Profiles, Vol. 19, Taylor and Francis, London and NY (2002), pp. 196–202. Klongpanichpak et al., 1997. S. Klongpanichpak, C. Toskulkao, P. Temcharoen, S. Apibal and T. Glinsukon, Lack of mutagenicity of stevioside and steviol in Salmonella typhimurium TA 98 and TA100. J. Med. Assoc. Thailand 80 (1997), pp. 121–128. Koyama et al., 2001. Koyama, E., Kitazawa, K., Ohori, Y., Sakai, N., Izawa, O., Kakegawa, K., Fujino, A., Ui, M., 2001. Intestinal degradation, absorption, and hepatic metabolism of the glycosidic sweeteners, Stevia mixture. In: Proceedings second IUPA-International Symposium on Sweeteners, Hiroshima, p.12. Koyama et al., 2003a. E. Koyama, K Kitazawa, Y Ohori, O. Izawa, K. Kakegawa, A. Fujino and M. Ui, In vitro metabolism of the glycosidic sweeteners, Stevia mixture and enzymatically modified Stevia in human intestinal microflora. Food Chem. Toxicol. 41 (2003), pp. 359–374. Abstract | Full Text + Links | PDF (379 K) Koyama et al., 2003b. E. Koyama, N. Sakai, Y Ohori, K Kitazawa, O. Izawa, K. Kakegawa, A. Fujino and M. Ui, Absorption and metabolism of the glycosidic sweeteners, Stevia related compounds in human and rat. Food Chem. Toxicol. 41 (2003), pp. 875–883. Abstract | Full Text + Links | PDF (325 K) Liu et al., 2003. J.-C. Liu, P.-K. Kao, P. Chan, Y.-H. Hsu, C.-C. Hou, G.-S. Lien, M.-H. Hsieh, Y.-J. Chen and J.-T. Cheng, Mechanism of the antihypertensive effect of stevioside in anesthesized dogs. Pharmacology 67 (2003), pp. 14–20. Matsui et al., 1996a. M. Matsui, K. Matsui, Y. Kawasaki, Y. Oda, T. Noguchi, Y. Kitagawa, M. Sawada, M. Hayashi, T. Nohmi, K. Yoshihira, M. Ishidate and T. Sofuni, Evaluation of the Genotoxicity of Stevioside and Steviol using six in vitro and one in vivo Mutagenicity Assays. Mutagenesis 11 (1996), pp. 573–579. Matsui et al., 1996b. M. Matsui, T. Sofuni and T. Nohmi, Regionally-targeted mutagenesis by metabolically-activated steviol: DNA sequence analysis of steviol-induced mutants of guanine phosphoribosyltransferase (gpt) gene of Salmonella typhimurium TM677. Mutagenesis 11 (1996), pp. 565–572. Medon et al., 1982. P.J. Medon, J.M. Pezzuto, J.M. Hovanec-Brown, N.P. Nanayakkara, D.D. Soejarto, S.K. Kamath and A.D. Kinghorn, Safety assesment of some Stevia rebaudiana sweet principles. Fed. Proc. 41 (1982), pp. 1568–1982. Melis, 1996. M.S. Melis, A crude extract of Stevia rebaudiana increases the renal plasma flow of normal and hypertensive rats. Braz. J. Med. Biol. Res. 29 (1996), pp. 669–675. Melis, 1999. M.S. Melis, Effects of chronic administration of Stevia rebaudiana on fertility in rats. J. Ethnopharmacol 167 (1999), pp. 157–161. Abstract | Full Text + Links | PDF (98 K) Mitsuhashi, 1976. Mitsuhashi H., 1976. Safety of stevioside. In: Tama Biochemical Co. Ltd. Report on Safety of Stevia, pp. 1–20. Mizutani and Tanaka, 2002. K. Mizutani and O. Tanaka, Use of Stevia rebaudiana sweeteners in Japan. In: A.D. Kinghorn, Editor, Stevia, the Genus Stevia. Medicinal and Aromatic Plants––Industrial Profiles, Vol. 19, Taylor and Francis, London and NY (2002), pp. 178–195. Mori et al., 1981. N. Mori, M. Sakanoue, M. Takcuchi, K. Shimpo and T. Tanabe, Effect of Stevioside on fertility in rats. J. Food Hyg. Soc. Jpn 22 (1981), pp. 409–414. Nakayama et al., 1986. K. Nakayama, D. Kasahara and F. Yamamoto, Absorption, distribution, metabolism and excretion of stevioside in rats. J. Food Hyg. Soc. Jpn 27 (1986), pp. 1–8. Oliveira-Filho et al., 1989. R.M. Oliveira-Filho, O.A. Uehara, C.A.S.A. Minett and L.B.S. Valle, Chronic administration of aqueous extract of Stevia rebaudiana (Bert.) Bertoni in rats: endocrine effects. Gen. Pharmac. 20 (1989), pp. 187–191. Abstract | Abstract + References | PDF (431 K) Orihara et al., 1991. Y. Orihara, K. Saiki and T. Furuya, Biotransformation of steviol by cultured cells of Eucalyptus perriniana and Coffea arabica. Phytochemistry 12 (1991), pp. 3989–3992. Abstract | Abstract + References | PDF (331 K) Pezzuto et al., 1985. J.M. Pezzuto, C.M. Compadre, S.M. Swanson, N.P.D. Nanayakkara and A.D. Kinghorn, Metabolically activated steviol, the aglycone of stevioside, is mutagenic. Proc. Nat. Acad. Sci. USA 82 (1985), pp. 2478–2482. Planas and Kuæ, 1968. G.M. Planas and J. Kuæ, Contraceptive properties of Stevia rebaudiana. Science 162 (1968), p. 1007. Pomaret and Lavieille, 1931. M. Pomaret and R. Lavieille, Le principe à saveur sucrée du Kaà-hè-é (Stevia rebaudiana Bertoni). Quelques propriétés physiologiques du Stévioside. Bull. Soc. Chim. Biol. 13 (1931), pp. 1248–1252. Procinska et al., 1991. E. Procinska, B.A. Bridges and J.R. Hanson, Interpretation of results with 8-azaguanine resistance system in Salmonella typhimurium: no evidence for direct acting mutagenesis by 15-oxosteviol, a possible metabolite of steviol. Mutagenesis 6 (1991), pp. 165–167. Richman et al., 1999. A.S. Richman, M. Gijzen, A.N. Starratt, Z. Yang and J.E. Brandle, Diterpene synthesis in Stevia rebaudiana: recruitment and up-regulation of key-enzymes from the gibberellin biosynthetic pathway. Plant J. 19 (1999), pp. 411–421. Ruddat et al., 1963. M. Ruddat, A. Lang and E. Mosettig, Gibberellin activity of steviol, a plant terpenoid. Naturwiss 50 (1963), p. 23. Setchell, 2002. K.D.R. Setchell, Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am. J. Clin. Nutr. 76 (2002), pp. 447–453. Shiotsu, 1996. S. Shiotsu, Fertility study of Stevia decoction in rats. Tech. J. Food Chem. Chemicals 4 (1996), pp. 108–113. Sinchomi and Marcorities, 1989. D. Sinchomi and P. Marcorities, Etude de l'activité anti-androgénique d'un extrait de Stevia rebaudiana Bertoni. Plantes médicinales et phytothérapie 23 (1989), pp. 282–287. Starrat et al., 2002. A.N. Starrat, C.W. Kirby, R. Pocs and J.E. Brandle, Rebaudioside F, a diterpene glycoside from Stevia rebaudiana. Phytochemistry 59 (2002), pp. 367–370. Temcharoen et al., 1998. P. Temcharoen, J. Pimbua, T. Glinsukon, W. Rojanapo and S. Apibal, Mutagenic activity of steviol to Salmonella typhimurium TM 677: Comparison of the activity of S9 liver fractions from five laboratory animal species. Bull. Health Sci. & Tech. 1 (1998), pp. 38–45. Temcharoen et al., 2000. P. Temcharoen, M. Suwannatrai, S. Klongpanichpak, S. Apibal, T. Glinsukon and C. Toskulkao, Evaluation of the effect of steviol on chromosomal damage using micronucleus test in three laboratory animal species. J. Med. Assoc. Thailand 83 (2000), pp. 101–108. Terai et al., 2002. T. Terai, H. Ren, G. Mori, Y. Yamaguchi and T. Hayashi, Mutagenicity of steviol and its oxidative derivatives in Salmonella typhimurium TM677. Chem. Pharm. Bull. 50 (2002), pp. 1007–1010. Toskulkao et al., 1997. C Toskulkao, L. Chaturat, P. Temcharoen and T. Glinsukon, Acute toxicity of stevioside, a natural sweetener, and its metabolite, steviol, in several animal species. Drug Chem. Toxicol. 20 (1997), pp. 31–44. Totté et al., 2000. N. Totté, L. Charon, M. Rohmer, F. Compernolle, I. Baboeuf and J.M.C. Geuns, Biosynthesis of the diterpenoid steviol, an ent-kaurene derivative from Stevia rebaudiana Bertoni, via the methylerythritol phosphate pathway. Tetrahedron Letters 41 (2000), pp. 6407–6410. Abstract | Full Text + Links | PDF (102 K) Totté et al., 2003. Totté, N., Van den Ende, W., Van Damme, E.J.M., Compernolle, F., Baboeuf, I. and Geuns, J. M.C. Cloning and heterologous expression of early genes in gibberellin and steviol biosynthesis via the methylerythritol phosphate pathway in Stevia rebaudiana Bertoni. Can. J. Bot. (in press). Toyoda et al., 1997. K. Toyoda, H. Matsui, T. Shoda, C. Uneyama, K. Takada and M. Takahashi, Assessment of the Carcinogenicity of Stevioside in F344 Rats. Food Chem. Toxicol. 35 (1997), pp. 597–603. Abstract | Full Text + Links | PDF (525 K) Usami et al., 1995. M. Usami, K. Sakemi, K. Kawashima, M. Tsuda and Y. Ohno, Teratogenicity study of stevioside in rats. Eisei Shikenjo Hokolu- Bull. Nat. Inst. Hyg. Sci. 113 (1995), pp. 31–35. Wasuntarawat et al., 1998. C. Wasuntarawat, P. Emcharoen, C. Toskulkao, P. Mungkornkarn, M. Suttajit and T. Glinsukon, Developmental toxicity of steviol, a metabolite of stevioside, in the hamster. Drug Chem. Toxicol. 21 (1998), pp. 207–222. WHO Food Additives, 1999. WHO Food Additives, 1999. Series 42: Safety evaluation of certain food additives "Stevioside", Genf, pp. 119–143. Wingard et al., 1980. R.E. Wingard, J.P. Brown, F.E. Enderlin, J.A. Dale, R.L. Hale and C.T. Seitz, Intestinal degradation and absorption of the glycosidic sweeteners stevioside and rebaudioside A. Experientia 36 (1980), pp. 519–520. Wood et al., 1996. D.J. Wood, A. Lirette, D.C. Crober and Ju-Hy, The effect of stevia as a feed sweetener on weight gain and feed consumption of broiler chickens. Can. J. Animal Sci. 76 2 (1996), pp. 267–269. Xili et al., 1992. L. Xili, B. Chengjiany, X. Eryi, S. Reiming, W. Yuengming, S. Haodong and H. Zhiyian, Chronic oral toxicity and carcinogenicity study of stevioside in rats. Food Chem. Toxicol. 30 (1992), pp. 957–965. Abstract | Abstract + References | PDF (600 K) Yamada et al., 1985. A. Yamada, S. Ohgaki, T. Noda and M. Shimizu, Chronic toxicity of dietary Stevia Extracts. J. Food Hyg. Soc. Jpn 26 (1985), pp. 169–183. Yamamoto et al., 1985. N.S. Yamamoto, K. Bracht, A.M. Ishii, E.L. Kemmelmeier, F.S. Alvarez and A. Bracht, Effect of steviol and its structural analogues on glucose production and oxygen uptake in rat renal tubules. Experientia 41 (1985), pp. 55–57. Yasukawa et al., 2002. K. Yasukawa, S. Kitanaka and S. Seo, Inhibitory effect of stevioside on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Biol. Pharm. Bull. 25 (2002), pp. 1488–1490. Yodyingyuad et al., 1991. V. Yodyingyuad and S. Bunyawong, Effect of stevioside on growth and reproduction. Human Reproduction 6 (1991), pp. 158–165. -- Matti Narkia |
#72
|
|||
|
|||
Splenda tablets - Why can't Johnson & Johnson sell them in the US?
"jamie" wrote in message ... Did you ever try it (NOW) after they enhanced the refinement? As I recall, when we both first tried it, it was a pale tan powder, with a disagreeable aftertaste. Later they refined it to a bright white powder, and I find it very acceptable to mix with other sweeteners. I did try the NOW white powder. I was able to tolerate it in pumpkin pie, where the various spices helped mask the taste, but for other things I still found the taste too strong. Debbie |
#73
|
|||
|
|||
Splenda tablets - Why can't Johnson & Johnson sell them in the US?
"sprudil" wrote in message news:qdM6c.109554$Up2.74269@pd7tw1no... "Julie Bove" wrote in message ... "hba1c" wrote in message om... As you may know, Splenda is available in a tablet form in many countries. snip I didn't know, but I would also have no use for them. If I do use Splenda, it is in cooking. Couldn't use tablets there! -- Type 2 http://users.bestweb.net/~jbove/ Of course you can. just crush them. Or dissolve it in a spoonful of warm water before stirriing it in: crushing those wienie tablets without *sproinging* them across the kitchen is a bit of an adventure. |
#74
|
|||
|
|||
Splenda tablets - Why can't Johnson & Johnson sell them in the US?
Nico Kadel-Garcia wrote:
"sprudil" wrote in message news:qdM6c.109554$Up2.74269@pd7tw1no... "Julie Bove" wrote in message ... "hba1c" wrote in message om... As you may know, Splenda is available in a tablet form in many countries. snip I didn't know, but I would also have no use for them. If I do use Splenda, it is in cooking. Couldn't use tablets there! -- Type 2 http://users.bestweb.net/~jbove/ Of course you can. just crush them. Or dissolve it in a spoonful of warm water before stirriing it in: crushing those wienie tablets without *sproinging* them across the kitchen is a bit of an adventure. Or simply buy the powder form. Servant to the humblest person in the universe, Andrew -- Dr. Andrew B. Chung, MD/PhD Board-Certified Cardiologist http://www.heartmdphd.com/ ** Who is the humblest person in the universe? http://makeashorterlink.com/?W1F522557 What is all this about? http://makeashorterlink.com/?J2DB148A7 Is this spam? http://makeashorterlink.com/?N69721867 |
#75
|
|||
|
|||
Splenda tablets - Why can't Johnson & Johnson sell them in the US?
"Dr. Andrew B. Chung, MD/PhD" wrote in message ws.com...
Nico Kadel-Garcia wrote: "sprudil" wrote in message news:qdM6c.109554$Up2.74269@pd7tw1no... "Julie Bove" wrote in message ... "hba1c" wrote in message om... As you may know, Splenda is available in a tablet form in many countries. snip I didn't know, but I would also have no use for them. If I do use Splenda, it is in cooking. Couldn't use tablets there! -- Type 2 http://users.bestweb.net/~jbove/ Of course you can. just crush them. Or dissolve it in a spoonful of warm water before stirriing it in: crushing those wienie tablets without *sproinging* them across the kitchen is a bit of an adventure. Or simply buy the powder form. Servant to the humblest person in the universe, Andrew -- Dr. Andrew B. Chung, MD/PhD Ah, but that would defeat the purpose! |
#76
|
|||
|
|||
Splenda tablets - Why can't Johnson & Johnson sell them in the US?
On 22 Mar 2004 12:34:30 -0800, tintinet wrote:
"Dr. Andrew B. Chung, MD/PhD" wrote in message ws.com... Nico Kadel-Garcia wrote: "sprudil" wrote in message news:qdM6c.109554$Up2.74269@pd7tw1no... "Julie Bove" wrote in message ... "hba1c" wrote in message om... As you may know, Splenda is available in a tablet form in many countries. snip I didn't know, but I would also have no use for them. If I do use Splenda, it is in cooking. Couldn't use tablets there! -- Type 2 http://users.bestweb.net/~jbove/ Of course you can. just crush them. Or dissolve it in a spoonful of warm water before stirriing it in: crushing those wienie tablets without *sproinging* them across the kitchen is a bit of an adventure. Or simply buy the powder form. Servant to the humblest person in the universe, Andrew -- Dr. Andrew B. Chung, MD/PhD Ah, but that would defeat the purpose! But the powdered form has maltodextrin or maltodextrin and dextrose, and it has a nasty aftertaste. -- Bob in CT Remove ".x" to reply |
#77
|
|||
|
|||
Splenda tablets - Why can't Johnson & Johnson sell them in the US?
I just sent them an email asking "when" the tablets would be available
due to the inconvenience of either toting your own packets or a restaurant not having splenda. Maybe if we all do that it will spark something? denise "Debbie Cusick" wrote in message ... "hba1c" wrote in message om... As you may know, Splenda is available in a tablet form in many countries. If enough people contacted Johnson & Johnson, maybe they would start selling them here. I have not asked for tablets, but I have written to J&J multiple times asking for a liquid version of Splenda (to avoid all the added maltodextrin filler in the splenda powder) but every time I have gotten back a canned response that "there is no market for it". I suspect I'd get the same response about the tablets. Debbie |
#78
|
|||
|
|||
Splenda tablets - Why can't Johnson & Johnson sell them in the US?
"Debbie Cusick" wrote in message ...
"hba1c" wrote in message om... As you may know, Splenda is available in a tablet form in many countries. If enough people contacted Johnson & Johnson, maybe they would start selling them here. I have not asked for tablets, but I have written to J&J multiple times asking for a liquid version of Splenda (to avoid all the added maltodextrin filler in the splenda powder) but every time I have gotten back a canned response that "there is no market for it". I suspect I'd get the same response about the tablets. Debbie BS, there's no market! They are just control freaks! |
#80
|
|||
|
|||
Splenda tablets - Why can't Johnson & Johnson sell them in the US?
BS, there's no market! They are just control freaks!
If they would sell the tablets and or liquid to me at the wholesale price (the price they sell them to distributors in other countries), I would be glad to set up a mail order business to tap into that "no market". |
Thread Tools | |
Display Modes | |
|
|
Similar Threads | ||||
Thread | Thread Starter | Forum | Replies | Last Post |
Splenda Tablets now selling to the USA | nightic | General Discussion | 0 | February 3rd, 2004 12:57 AM |